BioVie (BIVI) Institutional Ownership $1.65 -0.01 (-0.60%) Closing price 08/15/2025 04:00 PM EasternExtended Trading$1.67 +0.02 (+1.21%) As of 08/15/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for BioVie (NASDAQ:BIVI)CurrentInstitutional OwnershipPercentage4.59%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$10.63MNumber ofInstitutional Sellers(last 12 months)0 Get BIVI Insider Trade Alerts Want to know when executives and insiders are buying or selling BioVie stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BIVI Institutional Buying and Selling by Quarter BioVie Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/14/2025 Jane Street Group LLC61,742$57K0.0%N/A3.319% 8/12/2025 XTX Topco Ltd43,307$40K0.0%N/A2.328% 5/16/2025 NewEdge Advisors LLC54,100$53K0.0%+283.7%0.293% 2/17/2025 Squarepoint Ops LLC14,213$28K0.0%N/A0.080% 2/17/2025 Two Sigma Investments LP28,713$57K0.0%N/A0.162% 2/17/2025 Millennium Management LLC122,619$245K0.0%N/A0.690% 2/14/2025 Northern Trust Corp16,878$34K0.0%N/A0.095% 2/13/2025 NewEdge Advisors LLC14,100$28K0.0%+14,000.0%0.079% 2/13/2025 Bank of Montreal Can50,000$100K0.0%N/A0.281% 2/12/2025 Geode Capital Management LLC123,408$247K0.0%+223.3%0.694% Get the Latest News and Ratings for BIVI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioVie and its competitors with MarketBeat's FREE daily newsletter. 2/7/2025 Prosperity Wealth Management Inc.31,650$63K0.0%N/A0.178% 1/22/2025 Drive Wealth Management LLC60,000$120K0.0%N/A0.338% 1/15/2025 Sanders Morris Harris LLC40,000$85K0.0%N/A0.225% 5/14/2024Sheaff Brock Investment Advisors LLC51,400$27K0.0%+276.9%0.129% 5/7/2024CVI Holdings LLC599,897$317K0.3%N/A1.503% 11/7/2023 Jump Financial LLC10,000$34K0.0%N/A0.027% 10/30/2023 Summit Trail Advisors LLC10,100$34K0.0%N/A0.027% 10/25/2023 Crescent Grove Advisors LLC11,000$38K0.0%N/A0.030% 10/24/2023 Bank of New York Mellon Corp15,955$54K0.0%-51.2%0.043% 8/29/2023 Garde Capital Inc.24,163$104K0.0%+40.8%0.066% 7/20/2023AJ Wealth Strategies LLC23,474$101K0.0%+52.2%0.065% 7/11/2023 FNY Investment Advisers LLC8,986$38K0.0%N/A0.025% 5/4/2023 Barclays PLC54,117$437K0.0%+117.7%0.150% 4/28/2023AJ Wealth Strategies LLC15,428$125K0.0%N/A0.043% 2/24/2023 Garde Capital Inc.17,163$133K0.0%N/A0.049% 2/14/2023 683 Capital Management LLC16,110$125K0.0%N/A0.053% 2/14/2023swisspartners Ltd.294,346$2.29M2.9%+82.8%0.964% 2/7/2023 Commonwealth Equity Services LLC12,175$94K0.0%N/A0.040% 2/1/2023 Bank of Montreal Can10,000$78K0.0%N/A0.033% 1/30/2023 International Assets Investment Management LLC10,500$82K0.0%N/A0.034% 1/10/2023 FNY Investment Advisers LLC14,200$110K0.2%N/A0.047% 11/15/2022 Pura Vida Investments LLC36,617$91K0.0%N/A0.120% 5/4/2022swisspartners Ltd.10,367$1.87M1.3%-87.1%0.042% 2/14/2022 Long Focus Capital Management LLC20,000$90K0.0%N/A0.080% 11/16/2021swisspartners Ltd.80,521$542K0.4%+45.0%0.323% 11/12/2021 Renaissance Technologies LLC53,100$355K0.0%+90.3%0.214% 8/13/2021 Renaissance Technologies LLC27,900$473K0.0%N/A0.200% 8/13/2021 Geode Capital Management LLC22,898$388K0.0%+8.0%0.164% 8/13/2021 Vanguard Group Inc.97,804$1.66M0.0%+267.6%0.700% 8/11/2021swisspartners Ltd.55,521$941K0.7%+2.2%0.397% New law could create $3.7 trillion tsunami. (Ad)During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’s Project MAFA,” and it could soon return America to a “new” gold standard. The Trump administration, Wall Street, and Silicon Valley are all pushing it forward. The President himself calls the plan “incredible.” Already, it’s helping small plays jump as high as 300%, 318%, 520%, and even 600%.You can watch it right here.5/18/2021 Millennium Management LLC23,107$447K0.0%-3.7%0.166% (Data available from 1/1/2016 forward) BIVI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BIVI shares? During the previous two years, 19 institutional investors and hedge funds held shares of BioVie. The most heavily invested institutionals were CVI Holdings LLC ($317K), Geode Capital Management LLC ($247K), Millennium Management LLC ($245K), Drive Wealth Management LLC ($120K), Garde Capital Inc. ($104K), Bank of Montreal Can ($100K), and Sanders Morris Harris LLC ($85K).Learn more on BioVie's institutional investors. What percentage of BioVie's stock is owned by institutional investors? 4.59% of BioVie's stock is owned by institutional investors. Learn more on BIVI's institutional investor holdings. Which institutional investors have been buying BioVie's stock? Of the 18 institutional investors that purchased BioVie's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: CVI Holdings LLC ($599.90K), Millennium Management LLC ($122.62K), Geode Capital Management LLC ($85.23K), Jane Street Group LLC ($61.74K), Drive Wealth Management LLC ($60K), NewEdge Advisors LLC ($54K), and Bank of Montreal Can ($50K). How much institutional buying is happening at BioVie? Institutional investors have bought a total of 608,356 shares in the last 24 months. This purchase volume represents approximately $10.63M in transactions. Related Companies TherapeuticsMD Institutional Ownership Bullfrog AI Institutional Ownership Carisma Therapeutics Institutional Ownership IM Cannabis Institutional Ownership Flora Growth Institutional Ownership GeoVax Labs Institutional Ownership Phio Pharmaceuticals Institutional Ownership Longeveron Institutional Ownership Sonnet BioTherapeutics Institutional Ownership HOOKIPA Pharma Institutional Ownership This page (NASDAQ:BIVI) was last updated on 8/16/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored"I'm risking my reputation on this"A massive supply shock is building in the crypto market that could send Bitcoin to $300,000 this year. That...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioVie Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioVie With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.